Chemotherapy and immunotherapy are two distinct approaches for the treatment for high-grade gliomas. Used independently, neither is curative. However, if the appropriate chemotherapeutic agent is selected and its administration is timed in conjunction with immunotherapy, a potent synergistic effect may occur, resulting in a more favorable outcome.
Keywords: Immunotherapy, Chemotherapy, Glioblastoma multiforme, Glioma
Rights & PermissionsPrintExport